CRNX
Crinetics Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$83.87+0.01%
Price as of Jul 20, 2026
CRNX valuation
Crinetics Pharmaceuticals, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.91x
- Price / sales
- 489.42x
- Price / cash flow
- -21.35x
Enterprise value
- Enterprise value
- $7.6B
- EV / sales
- 420.60x
- EV / EBITDA
- -15.44x
- EV / EBIT
- -13.93x
- Market cap
- $8.8B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.